55th Annual Meeting of the European Association for the Study of Diabetes, Barcelona Risk factors for heart failure in the ACE trial population
C.A.B. Scott , J.J. McMurray, L. Rydén, Y. Sun, M. Tendera, R.L. Coleman, R.R. Holman
Diabetologia 2019;62:(Supp 1):S515 [Abstract]
55th Annual Meeting of the European Association for the Study of Diabetes, Barcelona Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance
S. Xu, C. Scott, R.L. Coleman, J. Tuomilehto, R.R. Holman
Diabetologia 2019;62:(Supp 1):S150 [Abstract]
2018
54th Annual Meeting of the European Association for the Study of Diabetes, Berlin Comparison of medical resources, costs, and health utilities among patients with CHD and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation Trial (ACE)
L. Mc Morrow, F. Becker, J. Leal, A.M. Gray, R. Coleman, H.C. Gerstein, L. Rydèn, R.R. Holman
Diabetelogia 2018;61:(Suppl 1):S344 [Abstract]
2007
2nd International Congress on Prediabetes and the Metabolic Syndrome, Barcelona A new era in the secondary prevention of CVD in prediabetes - the Acarbose Cardiovascular Evaluation (ACE) trial
Holman RR
Diabetes & Vascular Disease Research 2007;4:Suppl 1:S40 [Abstract]
2nd International Congress on Prediabetes and the Metabolic Syndrome, Barcelona Acarbose Cardiovascular Evaluation (ACE) Trial in prediabetic subjects
Holman RR, Pan CY
Diabetes & Vascular Disease Research 2007;4:Suppl 1:S128 [Abstract]
Diabetes Trials Unit, OCDEM, Churchill Hospital, Old Road, Headington, Oxford, OX3 7LJ
Tel: +44 (0)1865 857240 Email: dtu@dtu.ox.ac.uk
